Agenus Inc Mi Nk Therapeutics, Inc. (INKT) insider trading activity

Agenus Inc is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 21.8 Million shares of INKT, which is worth approximately $15.9 Million. The most recent transaction as insider was on Oct 16, 2023, when has been sold 429 shares (Common Stock) at a price of $1.1 per share, resulting in proceeds of $471. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.8M

0% 3M change

0% 12M change

Total Value Held $15.9 Million

AGENUS INC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 16 2023	BUY Open market or private purchase	$471 $1.1 p/Share	429 Added 0.0%	21,772,863 Common Stock
Oct 13 2023	BUY Open market or private purchase	$21,310 $1.1 p/Share	19,373 Added 0.09%	21,772,434 Common Stock
Oct 12 2023	BUY Open market or private purchase	$3,490 $1.1 p/Share	3,173 Added 0.01%	21,753,061 Common Stock
Oct 04 2023	BUY Open market or private purchase	$16,351 $1.09 p/Share	15,001 Added 0.07%	21,749,888 Common Stock
Aug 29 2023	BUY Open market or private purchase	$45,110 $1.52 p/Share	29,678 Added 0.14%	21,734,887 Common Stock
Aug 28 2023	BUY Open market or private purchase	$18,571 $1.45 p/Share	12,808 Added 0.06%	21,705,209 Common Stock
Aug 24 2023	BUY Open market or private purchase	$262,175 $1.54 p/Share	170,244 Added 0.78%	21,692,401 Common Stock
May 11 2023	BUY Open market or private purchase	$33,406 $1.43 p/Share	23,361 Added 0.11%	21,640,473 Common Stock
May 10 2023	BUY Open market or private purchase	$33,318 $1.51 p/Share	22,065 Added 0.1%	21,617,112 Common Stock
May 05 2023	BUY Open market or private purchase	$110,220 $1.1 p/Share	100,200 Added 0.46%	21,595,047 Common Stock
May 04 2023	BUY Open market or private purchase	$26,197 $1.22 p/Share	21,473 Added 0.1%	21,494,847 Common Stock
May 03 2023	BUY Open market or private purchase	$138,984 $1.08 p/Share	128,689 Added 0.6%	21,473,374 Common Stock
May 01 2023	SELL Other acquisition or disposition	-	4,988,273 Reduced 18.94%	21,344,685 Common Stock
Oct 19 2021	SELL Conversion of derivative security	-	5,451,958 Reduced 17.15%	26,332,958 Common Stock
Oct 19 2021	BUY Open market or private purchase	$16,800,000 $12.0 p/Share	1,400,000 Added 6.28%	20,881,000 Common Stock

Agenus Inc

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Value

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT

Account